Skip to main content
. 2020 Apr 10;12(2):124–130. doi: 10.4103/jpbs.JPBS_11_20

Table 2.

Perspective about biosimilar

S. no. Questions Option 1 Option 2
1. Are you aware about biosimilar? Yes No
2. Are patients are aware about use of biosimilars in cancer? Yes No
3. Does patient survival rate increased by use of biosimilars? Yes No
4. Are biosimilars easily assessable and affordable? Yes No
5. Biosimilars better option than original drugs? Agree Disagree
6. Have entry of biosimilars affected the price pattern of reference drugs? Yes No
7. Is it must for a pharmacist to notify about the prescribes that he or she intends to substitute for a prescribed product? Yes No
8. Can we see biosimilars replacing original drugs when they lose patents? Yes No
9. Are you aware about difference between a biosimilar and generic? Yes No
10. The latest regulation on biosimilars were issued in 2012 True False
11. Does regulation on biosimilars needs to be updated? Yes No
12. Does current regulation on biosimilars comply with needs of pharmaceutical industry and patient safety both? Yes No
13. Does biosimilars have some serious adverse effects? Yes No
14. Is biosimilars entry into the market a boon? True False
15. Whether industry is potentially beneficial for biosimilars, exclusive of its five years in the market. Yes No
16. Whether current regulation supports the industry. Yes No
17. Does India have clear cut guidelines for naming the biosimilar. Yes No
18. As per the mission of current government, the single-window system should be followed. Yes No
19. Is multiple data generation is essential in case of biosimilar. Yes No
20. As per guidelines, the biosimilar should be compared with approved products or not. Agree Disagree
21. The comparison should be made with innovator products or the approved products. Yes No
22. Personal are involved in biosimilar are well trained and qualified or not. Yes No
23. Is India good in export of biosimilar. Agree Degree
24. Bridge courses to empower to manpower involved in Biosimilar are utmost necessary. Yes No
25. Does Govt. of India includes biosimilar in its popular scheme in Ayushman Bharat Yes No